Teamtech Formwork IPO Day 1: GMP ₹0
Teamtech Formwork’s SME IPO on NSE kicked off its subscription journey today, May 19th, 2026, and the initial response is, to put it mildly, quiet. As Day 1 draws to a close, the subscription books are showing zero activity across all categories – Retail, High Networth Individuals (HNIs), and Qualified Institutional Buyers (QIBs). This isn’t what we typically see on the first day of an SME IPO, even for less hyped issues. The issue price is set at ₹61 per share, with a lot size of 2000 shares.
| Date | GMP | Est. Listing |
|---|---|---|
| 25 May | ₹0 | ₹63 |
| 23 May | ₹0 | ₹63 |
| 22 May | ₹0 | ₹63 |
| 21 May | ₹0 | ₹63 |
| 20 May | ₹0 | ₹63 |
Subscription Status
Let’s break down what these zero numbers actually mean. When you see 0x across Retail, NII (Non-Institutional Investors, a subset of HNIs), and QIBs on Day 1, it usually indicates a few things. Firstly, it could mean that investors are adopting a wait-and-watch approach. SME IPOs, especially those on the NSE, often see a surge in subscriptions towards the latter half of the IPO period. Many investors, particularly retail participants, prefer to gauge the sentiment and see how the book builds before committing their funds. This is a common strategy, and it doesn’t necessarily spell doom.
However, that said, the absence of even a single bid from HNIs or QIBs is something to observe. These are typically the more sophisticated investors who often assess an IPO’s fundamentals and potential listing gains more rigorously. Their silence today might suggest they’re still doing their homework, or perhaps they’re waiting for a clearer signal from the market or the Grey Market Premium (GMP). For a retail investor, seeing zero subscriptions might feel unnerving, but it’s crucial to remember that the IPO window is open until May 21st. There’s still ample time for interest to build.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 6.10x | |
| NII / HNI | 13.15x | |
| QIB | 4.28x | |
| Total | 7.09x |
| Date | Retail | NII | QIB | Total |
|---|---|---|---|---|
| 21 May | 6.10x | 13.15x | 4.28x | 7.09x |
| 20 May | 0.71x | 0.94x | 0.66x | 0.75x |
| 19 May | 0.35x | 0.79x | 0.66x | 0.53x |
GMP Update
Now, let’s talk about the Grey Market Premium (GMP). Yesterday, the GMP for Teamtech Formwork was at ₹0, and today, it remains unchanged at ₹0. This is a significant point. A GMP of ₹0 suggests that the grey market, which often acts as an unofficial barometer of listing expectations, isn’t pricing in any premium over the issue price of ₹61. In fact, it’s indicating a flat listing, meaning the stock is expected to open at its issue price. This lack of positive sentiment in the GMP could be contributing to the subdued subscription numbers we’re seeing. Investors often look for a healthy GMP to signal potential listing gains, and its absence here might be deterring some from applying aggressively on Day 1.
Should You Apply?
So, the big question: should you apply for the Teamtech Formwork IPO? Based on the data from Day 1, it’s a mixed bag. On one hand, the zero subscription across all categories and the flat GMP of ₹0 suggest a cautious market sentiment. This could mean limited listing gains, or even a potential risk of listing at par. The fact that the GMP hasn’t budged from zero is particularly noteworthy and warrants attention.
On the other hand, it’s only Day 1. SME IPOs have a tendency to see a last-minute rush, and the subscription numbers could change dramatically in the next two days. If you’re an investor who believes in the long-term prospects of Teamtech Formwork, and you’ve done your due diligence on the company’s financials and business model, then applying at the issue price might still be a reasonable proposition, especially if you’re looking for value rather than just quick listing gains. Remember, SEBI registered advisors often caution that GMP is not a definitive indicator and that fundamental analysis of the company is paramount.
For those who are risk-averse or solely focused on immediate listing profits, waiting to see how the subscription picks up in the remaining days, and if there’s any movement in the GMP, might be a wiser strategy. The IPO period ends on May 21st, 2026, giving you time to make an informed decision.